BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32219337)

  • 1. Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs.
    Lü J; Zhao Q; Ding X; Guo Y; Li Y; Xu Z; Li S; Wang Z; Shen L; Chen HW; Yu Z; Pestell RG
    Clin Sci (Lond); 2020 Apr; 134(7):791-805. PubMed ID: 32219337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.
    Wang G; Gormley M; Qiao J; Zhao Q; Wang M; Di Sante G; Deng S; Dong L; Pestell T; Ju X; Casimiro MC; Addya S; Ertel A; Tozeren A; Li Q; Yu Z; Pestell RG
    Theranostics; 2018; 8(8):2251-2263. PubMed ID: 29721077
    [No Abstract]   [Full Text] [Related]  

  • 3. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells.
    Sun X; Qin S; Fan C; Xu C; Du N; Ren H
    Oncol Rep; 2013 May; 29(5):2079-87. PubMed ID: 23467929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
    Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
    Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer.
    Yu Z; Wang L; Wang C; Ju X; Wang M; Chen K; Loro E; Li Z; Zhang Y; Wu K; Casimiro MC; Gormley M; Ertel A; Fortina P; Chen Y; Tozeren A; Liu Z; Pestell RG
    Nat Commun; 2013; 4():2812. PubMed ID: 24287487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
    Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
    J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-equivalent Roles of AGO1 and AGO2 in mRNA Turnover and Translation of Cyclin D1 mRNA.
    Ghosh U; Adhya S
    J Biol Chem; 2016 Mar; 291(13):7119-27. PubMed ID: 26846850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
    Hao L; ElShamy WM
    Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of the Argonaute protein PiwiL2 and piRNAs in adult mouse mesenchymal stem cells.
    Wu Q; Ma Q; Shehadeh LA; Wilson A; Xia L; Yu H; Webster KA
    Biochem Biophys Res Commun; 2010 Jun; 396(4):915-20. PubMed ID: 20460113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
    Lee RJ; Albanese C; Stenger RJ; Watanabe G; Inghirami G; Haines GK; Webster M; Muller WJ; Brugge JS; Davis RJ; Pestell RG
    J Biol Chem; 1999 Mar; 274(11):7341-50. PubMed ID: 10066798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-Element-Induced Wimpy Testis Proteins and P-Element-Induced Wimpy Testis-Interacting RNAs Expression in Ovarian Cancer Stem Cells.
    Sohn EJ; Oh SO
    Genet Test Mol Biomarkers; 2023 Feb; 27(2):56-64. PubMed ID: 36853842
    [No Abstract]   [Full Text] [Related]  

  • 17. Starvation stress attenuates the miRNA-target interaction in suppressing breast cancer cell proliferation.
    Lü J; Zhang C; Han J; Xu Z; Li Y; Zhen L; Zhao Q; Guo Y; Wang Z; Bischof E; Yu Z
    BMC Cancer; 2020 Jul; 20(1):627. PubMed ID: 32631271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
    Yu Z; Wang C; Wang M; Li Z; Casimiro MC; Liu M; Wu K; Whittle J; Ju X; Hyslop T; McCue P; Pestell RG
    J Cell Biol; 2008 Aug; 182(3):509-17. PubMed ID: 18695042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
    Lin Z; Zhang X; Zhao F; Ru S
    Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.